newsfilter
← Latest News
ACCESS Newswire·

MorphoSys AG Reports Second Quarter and First Half 2021 Results

- Monjuvi U.S. net product sales of € 14.9 million (US$ 18.0 million), 16% growth Q-Q- MorphoSys announced and subsequently completed its acquisition of Constellation Pharmaceuticals- Announced and closed ~US$ 2.0 billion strategic funding partnership